MTOR and breast cancer: Therefore, we aim to provide a comprehensive review on the impact of various endocrine therapeutic strategies on the TIM in BC covering SERDs, SERMs, AIs, GnRHa and inhibitors of PI3K, AKT, mTOR and CDK4/6.